SCHEMBL3520095

SCHEMBL3520095

COc1cccc(CNc2cc(=O)n(O)c3ncccc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.51
LIPG Q9Y5X9 1/20 0.51
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
AURKA O14965 1/20 0.47
RPS6KB1 P23443 1/20 0.47
ACP1 P24666 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
ABCB1 P08183 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
EGFR P00533 1/20 0.46
IGF1R P08069 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
KAT2B Q92831 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
ENPP2 Q13822 1/20 0.45
PDE9A O76083 1/20 0.45
IDH1 O75874 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3519313 0.89 NCF1 (0.47) GRM2MAPTTHRBAURKARPS6KB1
SCHEMBL3516223 0.84 BACE1 (0.49) GRM2LIPGMAPTRPS6KB1HPGD
SCHEMBL3519288 0.81 HDAC3 (0.44) MAPTTHRBHPGDHDAC8KAT2B
SCHEMBL3538616 0.81 KMT2A (0.46) MAPTRPS6KB1KMT2AALDH1A1PDE9A
SCHEMBL3517421 0.81 ADRA2C (0.43) RPS6KB1KMT2AHDAC8POLB
SCHEMBL3516789 0.80 IDH1 (0.47) MAPTAURKARPS6KB1ACP1HPGD
SCHEMBL16274608 0.79 TP53 (0.48) GRM2MAPTAURKARPS6KB1KMT2A
SCHEMBL3516561 0.79 AURKA (0.41) MAPTAURKARPS6KB1KMT2AALDH1A1
SCHEMBL3517673 0.77 PARP1 (0.42) POLB
SCHEMBL3516034 0.77 AURKA (0.43) MAPTAURKARPS6KB1ACP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL GRM2 4876/4885LIPG 2301/4885MAPT 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.